Shivayogi Charantimath
Research Subjects
Research Interests
Shivayogi Charantimath has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Anabelle Fernandes
Department of Oral Medicine and Radiology, KAHER's KLE Vishwanath Katti Institute of Dental Sciences, Constituent Unit of KLE Academy of Higher Education and Research, Nehru Nahar, Belagavi, Karnataka, 590010, India
1 shared publication - Jayraj B. Malik
Department of Oral Medicine and Radiology, KAHER's KLE Vishwanath Katti Institute of Dental Sciences, Constituent Unit of KLE Academy of Higher Education and Research, Nehru Nahar, Belagavi, Karnataka, 590010, India
1 shared publication - Sulem Ansari
KAHER’s KLE VK Institute of Dental Sciences
1 shared publication - Vaishali Keluskar
Department of Oral Medicine, Diagnosis and Radiology, KAHER’s KLE Vishwanath Katti Institute of Dental Sciences, JNMC Campus, Nehru Nagar, Belagavi, Belagavi, India
1 shared publication
Latest Publications
- Open Access
- 22 August 2022
- Published by Instituto de Filosofia e Ciências Humanas - UNICAMP in Brazilian Journal of Oral Sciences
- Vol. 21, e227017
COVID-19 associated rhinomaxillary mucormycosis
During COVID-19 pandemic, fulminant deep fungal infection started emerging in India, known as Mucormycosis. This type of mucormycosis was termed as COVID-19 associated mucormycosis (CAM). These patients had previous history of COVID-19 infection. Such cases were mainly reported in immunocompromised patients such as patients with poorly controlled diabetes and chronic renal diseases etc. Rhinomaxillary mucormycosis is an aggressive, fulminant, fatal deep fungal infection of head and neck region. Early diagnosis and prompt treatment can reduce the mortality and morbidity associated with the disease; hence we present case series of rhinomaxillary mucormycosis to create awareness amongst dental surgeons.
- 22 August 2022
- Published by Instituto de Filosofia e Ciências Humanas - UNICAMP in Brazilian Journal of Oral Sciences
- Vol. 21, e227017
Open AccessCOVID-19 associated rhinomaxillary mucormycosis
During COVID-19 pandemic, fulminant deep fungal infection started emerging in India, known as Mucormycosis. This type of mucormycosis was termed as COVID-19 associated mucormycosis (CAM). These patients had previous history of COVID-19 infection. Such cases were mainly reported in immunocompromised patients such as patients with poorly controlled diabetes and chronic renal diseases etc. Rhinomaxillary mucormycosis is an aggressive, fulminant, fatal deep fungal infection of head and neck region. Early diagnosis and prompt treatment can reduce the mortality and morbidity associated with the disease; hence we present case series of rhinomaxillary mucormycosis to create awareness amongst dental surgeons.